ClinicalTrialsFinder

Antisynthetase Syndrome Clinical Trials in Nanjing, Jiangsu

1 recruitingNanjing, Jiangsu, China

Showing 1–1 of 1 trials

Recruiting
Early Phase 1

An Exploratory Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Antisynthetase Antibody Syndrome and Rheumatoid Arthritis

Rheumatoid ArthritisAntisynthetase Syndrome
The First Affiliated Hospital with Nanjing Medical University24 enrolled1 locationNCT06613490